ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors

Escorcia, FE; Houghton, JL; Abdel-Atti, D; Pereira, PR; Cho, A; Gutsche, NT; Baidoo, KE; Lewis, JS

Escorcia, FE (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10065 USA.; Escorcia, FE (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10065 USA.; Escorcia, FE (corresponding author), NCI, Mol Imaging Program, Ctr Canc Res, NIH, Bethesda, MD 20814 USA.

THERANOSTICS, 2020; 10 (1): 151

Abstract

Background: Pancreatic ductal adenocarcinoma (PDAC) has limited standard of care therapeutic options. While initially received with enthusiasm, result......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索